Market Cap

Epigenomics AG Market Capitalization:

€6.2 Million

EUR as of Jan. 1, 2023

US$6.6 Million

business Epigenomics AG Company Profile

Epigenomics AG Main Stock Listings

Market Capitalization History of Epigenomics AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $215.98 B
Danaher $190.92 B
Siemens Healthineers AG $55.11 B
Agilent Technologies, Inc. $44.42 B
DexCom, Inc. $44.32 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of Epigenomics AG market cap

Date Market Cap YoY Change
Jan. 1, 2023 €6.2 M 167.18%
Jan. 1, 2022 €2.3 M -77.18%
Jan. 1, 2021 €10.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Epigenomics AG Categories

Germany languages Healthcare languages Diagnostics & Research
Germany Healthcare Germany Diagnostics & Research

Stocks & Indices

Epigenomics AG has the following listings and related stock indices.


Stock: FSX: ECX

Stock: XETR: ECX

Stock: OTC: EPGNY

Stock: OTC: EPGNF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.